These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29793627)

  • 1. Smartwatches in the Fight Against Atrial Fibrillation: The Little Watch That Could.
    Mela T
    J Am Coll Cardiol; 2018 May; 71(21):2389-2391. PubMed ID: 29793627
    [No Abstract]   [Full Text] [Related]  

  • 2. Six-lead device superior to single-lead smartwatch ECG in atrial fibrillation detection.
    Scholten J; Jansen WPJ; Horsthuis T; Mahes AD; Winter MM; Zwinderman AH; Keijer JT; Minneboo M; de Groot JR; Bokma JP
    Am Heart J; 2022 Nov; 253():53-58. PubMed ID: 35850242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passive Detection of Atrial Fibrillation Using a Commercially Available Smartwatch.
    Tison GH; Sanchez JM; Ballinger B; Singh A; Olgin JE; Pletcher MJ; Vittinghoff E; Lee ES; Fan SM; Gladstone RA; Mikell C; Sohoni N; Hsieh J; Marcus GM
    JAMA Cardiol; 2018 May; 3(5):409-416. PubMed ID: 29562087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The prediction of atrial fibrillation recurrence after electrical cardioversion with P wave signal averaged EKG].
    Budeus M; Hennersdorf M; Perings C; Strauer BE
    Z Kardiol; 2004 Jun; 93(6):474-8. PubMed ID: 15252741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wavelet transform analysis predicts outcome of DC cardioversion for atrial fibrillation patients.
    Watson JN; Addison PS; Uchaipichat N; Shah AS; Grubb NR
    Comput Biol Med; 2007 Apr; 37(4):517-23. PubMed ID: 17011542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome after cardioversion of atrial fibrillation: prediction of recurrence with P wave signal averaged ECG and chemoreflexsensitivity.
    Budeus M; Wieneke H; Sack S; Erbel R; Perings C
    Int J Cardiol; 2006 Oct; 112(3):308-15. PubMed ID: 16309759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular pauses during atrial fibrillation predict relapse after electrical cardioversion: a prospective study.
    Gallagher MM; Guo XH; Poloniecki J; Camm AJ
    Pacing Clin Electrophysiol; 2010 Aug; 33(8):934-8. PubMed ID: 20487347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular fibrillation following successful DC cardioversion for atrial fibrillation.
    Caldwell JC; Woolfson P; Clarke B; Garratt CJ
    Pacing Clin Electrophysiol; 2012 Dec; 35(12):e361-4. PubMed ID: 21251025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular fibrillation during electrical cardioversion of pre-excited atrial fibrillation.
    Adlam D; Azeem T
    Postgrad Med J; 2003 May; 79(931):297-9. PubMed ID: 12782780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardioversion of atrial fibrillation].
    Jóanesarson J; Riahi S; Hjortshøj S
    Ugeskr Laeger; 2013 Oct; 175(43):2549-53. PubMed ID: 24629150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUCCESSFUL USE OF EXTERNAL ELECTRICAL CARDIOVERSION IN THE TREATMENT OF VENTRICULAR FIBRILLATION CAUSED BY QUINIDINE.
    RUBEIZ GA; EL-HAJJ M; TOUMA A
    Am J Cardiol; 1965 Jul; 16():118-21. PubMed ID: 14314195
    [No Abstract]   [Full Text] [Related]  

  • 12. [Success of pharmacologic cardioversion and electric cardioversion in patients with atrial fibrillation or flutter in a 5-year retrospective study].
    Bugán V; Renker B; Brunclík P; Baraniková D; Augustín E
    Vnitr Lek; 1994 Apr; 40(4):219-22. PubMed ID: 8184582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal timing of electrical cardioversion in patients with persistent atrial fibrillation.
    Naji F; Vokac D; Kanic V; Sabovic M
    Med Sci Monit; 2010 Oct; 16(10):CR464-8. PubMed ID: 20885349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrical cardioversion of atrial fibrillation in a case of dextrocardia.
    Gorenek B; Kuskus S; Kudaiberdieva G; Citak A; Ata N; Birdane A; Goktekin O; Cavusoglu Y; Unalir A; Timuralp B
    Can J Cardiol; 2004 Jun; 20(8):819-21. PubMed ID: 15229765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrocardiographic markers of cardioversion success in patients with atrial fibrillation or flutter.
    Heston TF; Cheng A
    South Med J; 2009 Sep; 102(9):877-8. PubMed ID: 19668046
    [No Abstract]   [Full Text] [Related]  

  • 16. [Internal cardioversion in chronic atrial fibrillation].
    Mendoza González C; Iturralde Torres P; Guevara Valdivia ME; Nava Townsend S; Rodríguez Chávez L; Rodríguez Briones I
    Arch Cardiol Mex; 2002; 72(2):138-44. PubMed ID: 12148333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute management of atrial fibrillation: Part I. Rate and rhythm control.
    King DE; Dickerson LM; Sack JL
    Am Fam Physician; 2002 Jul; 66(2):249-56. PubMed ID: 12152960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient electrocardiographic changes of left atrial hypertrophy following successful cardioversion for atrial fibrillation.
    Hendrix GH; Davis RE
    South Med J; 1973 Jun; 66(6):729-30. PubMed ID: 4267734
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk factors for atrial fibrillation recurrence: a literature review.
    Vizzardi E; Curnis A; Latini MG; Salghetti F; Rocco E; Lupi L; Rovetta R; Quinzani F; Bonadei I; Bontempi L; D'Aloia A; Dei Cas L
    J Cardiovasc Med (Hagerstown); 2014 Mar; 15(3):235-53. PubMed ID: 23114271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability in fully conscious patients of transvenous low-energy internal atrial cardioversion for atrial fibrillation.
    Boriani G; Biffi M; Bronzetti G; Ayers GM; Zannoli R; Branzi A; Capucci A; Magnani B
    Am J Cardiol; 1998 Jan; 81(2):241-4. PubMed ID: 9591914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.